Table 5. Reported number of pre- and post-operative topical glaucoma medications in studies considering phacoemulsification as a solo procedure.
| Author (Year) | N | Baseline Topical Glaucoma Medications(Mean) | Baseline Topical Glaucoma Medications(SD) | Post-operative Topical Glaucoma Medications(Mean) | Post-operative Topical Glaucoma Medications(SD) | Mean Reduction in Medications |
|---|---|---|---|---|---|---|
| Altan-Yaycioglu (2009) [41] | 26 | 1 | 0 | 1 | 0 | 0.0 |
| Bowling (2009) [42] | 51 | 1.5 | 0.5 | 0.6 | 0.5 | 0.9 |
| Chang (2012) [43] | 29 | 2.13 | 1.13 | 1.96 | 1.44 | 0.17 |
| Chihara (2010) [44] | 208 | 0.68 | 0.74 | 0.36 | 0.62 | 0.32 |
| Guan (2013) [46] | 103 | 1.5 | 1.3 | 1.5 | 1.3 | 0.0 |
| Khondkaryan (2012) [48] | 20 | 1.4 | 1.47 | 0.8 | 1.11 | 0.6 |
| Klink (2005) [49] | 36 | 0.8 | 0.5 | 0.8 | 0.5 | 0.0 |
| Ismi (2013) [50] | 21 | 1.48 | 0.5 | 1.24 | 0.5 | 0.24 |
| Mathalone (2005) [52] | 24 | 1.5 | 0.9 | 1.1 | 1.12 | 0.4 |
| Park (2004) [54] | 103 | 1.3 | 0.6 | 1 | 0.5 | 0.3 |
| Poley (2010) [55] | 124 | 1.3 | 0.7 | 1 | 0.7 | 0.3 |
| Pohjalainene (2001) [56] | 38 | 1.7 | 0.5 | 1.3 | 0.5 | 0.4 |
| Sharma (2008) [58] | 22 | 0.6 | 3.09 | 0.45 | 1.6 | 0.15 |
| Shingleton (2006) [59] | 55 | 1.1 | 0.5 | 1.1 | 0.7 | 0.0 |
| Shingleton (2008a) [60] | 137 | 0.12 | 0.03 | 0.09 | 0.24 | 0.03 |
| Shingleton (2008b) [61] | 240 | 1.6 | 0.9 | 1 | 1.1 | 0.6 |
| Slabaugh (2014) [62] | 157 | 1.85 | 1.01 | 1.92 | 1.07 | -0.07 |
Weighted mean reduction in topical glaucoma medications following Phaco only was 0.23.